Otsuka Pharmaceutical Co., Ltd v Generic Health Pty Ltd

Link copied
Case Copied 18 min read

FEDERAL COURT OF AUSTRALIA

Otsuka Pharmaceutical Co., Ltd v Generic Health Pty Ltd [2019] FCA 230

File numbers: NSD 121 of 2012
NSD 837 of 2015
Judge: YATES J
Date of judgment: 27 February 2019
Catchwords: PRACTICE AND PROCEDURE – proceedings to enforce undertakings as to damages given in patent infringement proceedings – where several enforcement proceedings commenced – where allegations in one set of enforcement proceedings admitted but corresponding allegations in another set of enforcement proceedings denied – whether inconsistent allegations can be pleaded – whether pleading of denials is an abuse of the Court’s process – whether pleading of denials should be struck out
Legislation:

Federal Court of Australia Act 1976 (Cth) s 4

Federal Court Rules 2011, rr 16.06, 16.21(1)(f), 22.07, 30.11

National Health Act 1953 (Cth)

Cases cited:

Batistatos v Roads and Traffic Authority of New South Wales [2006] HCA 27; (2006) 226 CLR 256

Issitch v Worrell (2000) 172 ALR 586

J C Decaux Pty Ltd v Adhsel Street Furniture Pty Ltd [2000] FCA 1118; (2000) 178 ALR 339

Laws v Australian Broadcasting Tribunal (1990) 170 CLR 70

Stohl Aviation v Electrum Finance Pty Ltd (1984) 5 FCR 187

Surfing Hardware International Holdings Pty Ltd v McCausland [2008] FCA 1522; (2008) 171 FCR 533

UBS AG v Tyne [2018] HCA 45

Date of hearing: 10 December 2018
Registry: New South Wales
Division: General Division
National Practice Area: Intellectual Property
Sub-area: Patents and associated Statutes
Category: Catchwords
Number of paragraphs: 41
Counsel for the Applicants/ Appellants: Mr J Sheahan QC
Mr J Hutton
Solicitor for the Applicants/ Appellants: Allens
Counsel for the Respondent  The Respondent did not appear
Counsel for the Commonwealth of Australia: Mr P J Brereton SC
Mr P Knowles
Ms F Roughley
Solicitor for the Commonwealth of Australia: Corrs Chambers Westgarth

ORDERS

NSD 121 of 2012
NSD 837 of 2015
BETWEEN:

OTSUKA PHARMACEUTICAL CO., LTD

First Applicant / First Appellant

BRISTOL-MYERS SQUIBB COMPANY

Second Applicant / Second Appellant

AND:

GENERIC HEALTH PTY LTD (ACN 110 617 859)

Respondent

COMMONWEALTH OF AUSTRALIA

Other

JUDGE:

YATES J

DATE OF ORDER:

27 FEBRUARY 2019

THE COURT ORDERS THAT:

1.The interlocutory application filed on 16 November 2018 by the Commonwealth of Australia (the Commonwealth) be dismissed.

2.The Commonwealth pay the costs of Otsuka Pharmaceutical Co., Ltd and Bristol-Myers Squibb Company of and incidental to the interlocutory application.

Note:   Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.


REASONS FOR JUDGMENT

YATES J:

INTRODUCTION

  1. The Commonwealth of Australia (the Commonwealth) applies to strike out paragraphs 78, 79, 80 and 82 of the Points of Defence which have been filed by Otsuka Pharmaceutical Co., Ltd (Otsuka) and Bristol-Myers Squibb Company (BMS) (together, Otsuka/BMS) in response to Amended Points of Claim filed by the Commonwealth in proceedings commenced by the Commonwealth to enforce undertakings as to damages given by Otsuka/BMS.

  2. The undertakings were given by Otsuka/BMS in patent infringement proceedings commenced in…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Otsuka Pharmaceutical Co., Ltd v Generic Health Pty Ltd and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2019] FCA 230
Decision Date

CaseChat Overview and Summary

In the matter of Otsuka Pharmaceutical Co., Ltd v Generic Health Pty Ltd, the court dealt with an application by the Commonwealth of Australia to enforce undertakings as to damages given in patent infringement proceedings. The application sought to strike out certain paragraphs of the Points of Defence filed by the defendants, which contained inconsistent allegations and denials. The defendants argued that the inconsistent pleadings were permissible and not an abuse of the Court’s process. The court found that inconsistent pleadings are not prohibited by the Federal Court Rules and that the defendants had a sufficient basis to plead the inconsistent allegations. The court also noted that the several proceedings were separate and distinct, and that the rules do not speak across all proceedings involving a particular party.

The court considered whether inconsistent pleadings in different proceedings are permissible under the Federal Court Rules. The Commonwealth argued that inconsistent pleadings are prohibited by r 16.06 of the Rules, while the defendants argued that the rule does not prohibit inconsistent pleadings as long as they are pleaded as alternatives. The court found that r 16.06 is not a prohibition on pleading inconsistent allegations, but rather a rule ensuring clarity in pleading. The court also found that a party cannot plead inconsistent facts where one set of facts must be known to be false. However, the court did not find that the defendants had pleaded inconsistent facts with knowledge that they were false.

The court also considered whether pleading inconsistent allegations in separate proceedings is an abuse of the Court’s process. The defendants argued that the several proceedings were separate and distinct, and that the rules do not speak across all proceedings involving a particular party. The court agreed with the defendants and found that the separate and distinct nature of the proceedings meant that the rules did not prohibit pleading inconsistent allegations. The court also noted that each interlocutory application was an “incidental proceeding” in connection with the primary proceeding and the appeal proceeding, respectively.

The court dismissed the Commonwealth’s application to strike out the inconsistent pleadings and ordered that the Commonwealth pay the costs of Otsuka Pharmaceutical Co., Ltd and Bristol-Myers Squibb Company. The court found that the defendants had a sufficient basis to plead the inconsistent allegations and that the pleading of the inconsistent allegations was not an abuse of the Court’s process. The court also found that the separate and distinct nature of the several proceedings meant that the rules did not prohibit pleading inconsistent allegations.

Orders

Orders of the court

1. The interlocutory application filed on 16 November 2018 by the Commonwealth of Australia (the Commonwealth) be dismissed.

2. The Commonwealth pay the costs of Otsuka Pharmaceutical Co., Ltd and Bristol-Myers Squibb Company of and incidental to the interlocutory application.

Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

The Commonwealth further submits that if the challenged paragraphs are to stand, complex questions will be raised as to the operation of r 22.07, which permits the Court to give judgment or to make an order on admissions that have been made.CONCLUSIONS AND REASONS I do not accept that paragraphs 78, 79, 80 and 82 of the Points of Defence filed in the Commonwealth’s enforcement proceedings offend r 16.06 or any of the other pleading rules, or that the pleading of the denials and affirmative allegations in those paragraphs is an abuse of the Court’s process. I accept that the separate Points of Defence filed in respect of Generic Health’s enforcement proceedings and in respect of the Commonwealth’s enforcement proceedings are, each, a “defence”, and hence a “pleading”, for the purpose of the Rules. But I do not accept the Commonwealth’s interpretation of r 16.06. Rule 16.06 does not prohibit “inconsistent pleadings” as the Commonwealth submits. Rather, the rule contemplates the possibility of pleading inconsistent allegations of fact or inconsistent grounds or claims, and permits that to be done, provided the inconsistent allegations, grounds or claims are pleaded as alternatives. In this way, the rule is directed to ensuring clarity in pleading. It is not in and of itself a prohibition on the allegations, grounds or claims that a party can plead in a given proceeding. That said, a party cannot plead inconsistent facts where one set of facts must be known to the pleading party to be false. Such a pleading would be embarrassing and liable to be struck out for that reason or as an abuse of the Court’s process: Issitch v Worrell (2000) 172 ALR 586 at [32]; J C Decaux Pty Ltd v Adhsel Street Furniture Pty Ltd [2000] FCA 1118; (2000) 178 ALR 339 at [21]; Surfing Hardware International Holdings Pty Ltd v McCausland [2008] FCA 1522; (2008) 171 FCR 533 at [57] – [58]. However, it is not suggested that Otsuka/BMS lack a sufficient basis to put in issue, in the way they have, the matters pleaded in paragraphs 78, 79, 80 and 82 of the Points of Claim filed in the Commonwealth’s enforcement proceedings. It is certainly not suggested that they have done so with knowledge that the matters pleaded are false. It is also important to bear in mind that, although Generic Health and the Commonwealth have each filed interlocutory applications in the primary proceeding and the appeal proceeding: (a)each interlocutory application is an “incidental proceeding” (see the definition of “proceeding” in s 4 of the Federal Court of Australia Act 1976 (Cth)) in connexion with the primary proceeding and the appeal proceeding, respectively; and(b)each incidental proceeding brought by Generic Health to enforce its claims for compensation is separate and distinct from each incidental proceeding brought by the Commonwealth to enforce its claims for compensation. The separate and distinct nature of these incidental proceedings is not gainsaid by the fact that, in each case, enforcement is sought on the same undertakings given in support of the same interlocutory relief. I do not understand r 16.06 to be a rule that “speaks across all proceedings” involving a particular party where, as here, the several proceedings are commenced at different times and concern separate and distinct claims involving different claimants.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.